Correlation Between Thrombotic Parameter D-Dimer and Disease Severity in Patients Infected With SARS-CoV-2 in Da Nang City, Vietnam

Thuy Thi Le; Nga Thi Quynh Nguyen; Van Cao; Cong Phi Dang; Thu Thi Hoai Nguyen

doi:10.33165/rmj.48.01.e270167

Authors

Thuy Thi Le Faculty of Medical Laboratory Science, Da Nang University of Medical Technology and Pharmacy, Da Nang, Vietnam https://orcid.org/0009-0002-5077-7099
Nga Thi Quynh Nguyen Faculty of Medical Laboratory Science, Da Nang University of Medical Technology and Pharmacy, Da Nang, Vietnam https://orcid.org/0009-0004-7808-3878
Van Cao Faculty of Medical Laboratory Science, Da Nang University of Medical Technology and Pharmacy, Da Nang, Vietnam https://orcid.org/0009-0009-4783-6490
Cong Phi Dang Faculty of Medical Laboratory Science, Da Nang University of Medical Technology and Pharmacy, Da Nang, Vietnam https://orcid.org/0009-0007-3058-1589
Thu Thi Hoai Nguyen Faculty of Medical Laboratory Science, Da Nang University of Medical Technology and Pharmacy, Da Nang, Vietnam / Biomedical Science Program, Department of Biochemistry, Graduate School, Hanoi Medical University, Ha Noi, Vietnam https://orcid.org/0009-0007-6252-1249

DOI:

https://doi.org/10.33165/rmj.48.01.e270167

Keywords:

COVID-19 patients, D-dimer, ROC curve, Thrombosis parameter

Abstract

Background: The COVID-19 pandemic posed a significant healthcare crisis due to the emergence of acute respiratory infections, leading to severe complications such as thrombosis. Meanwhile, the D-dimer index serves as a dependable routine diagnostic marker for thrombosis. Therefore, it is hypothesized that D-dimer could serve as a potential prognostic marker for COVID-19 infection.

Objective: To assess the association between D-dimer levels and the severity of COVID-19 among patients in the Vietnamese central coastal region.

Methods: A retrospective cross-sectional study was conducted at Da Nang Hospital for Pulmonary Diseases and its satellites on patients admitted for COVID-19 from September 2021 to April 2022. Clinical data were analyzed using the chi-square test. The receiver operating characteristic (ROC) curve was used to determine the best cut-off for D-dimer levels that differentiate between mild and severe cases amongst COVID-19 positive patients.

Results: This study comprised of 205 confirmed COVID-19 patients (mean [SD] age, 66.71 [18.80] years). The participants were divided into 2 groups based on their D-dimer levels: those with D-dimer levels greater than 500 µg/L or less than 500 µg/L. The median D-dimer level of each group were 1507.50 µg/L and 302 µg/L, respectively. Patient age and a history of diabetes correlated with D-dimer elevation in COVID-19 patients. The ROC curve indicated that D-dimer of greater than 638 µg/L was associated with severe disease (sensitivity 80%, specificity 90.8%, area under the curve [AUC] = 0.900).

Conclusions: Elevated D-dimer levels was associated with more severe instances of COVID-19 with levels exceeding 638 µg/L demonstrating high sensitivity and specificity.

References

Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157-160. doi:10.23750/abm.v91i1.9397

Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. doi:10.1056/NEJMoa2002032

Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-260. doi:10.1038/s41569-020-0360-5

Emmi A, Boura I, Raeder V, et al. Covid-19, nervous system pathology, and Parkinson’s disease: bench to bedside. Int Rev Neurobiol. 2022;165:17-34. doi:10.1016/bs.irn.2022.06.006

Maffei M, Mazzatenta A, Origlia N. Editorial: loss of taste and smell in COVID-19 patients: a prognostic tool and a starting point to investigate the action of SARS-CoV-2 in the central nervous system. Front Cell Neurosci. 2023;17:1191227. doi:10.3389/fncel.2023.1191227

Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;43(7):1027-1031. doi:10.1007/s40618-020-01276-8

Tufan A, Avanoğlu Güler A, Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci. 2020;50(SI-1):620-632. doi:10.3906/sag-2004-168

Cappell MS, Friedel DM. Gastrointestinal bleeding in COVID-19-infected patients. Gastroenterol Clin North Am. 2023;52(1):77-102. doi:10.1016/j.gtc.2022.10.004

Kaye AD, Okeagu CN, Tortorich G, et al. COVID-19 impact on the renal system: pathophysiology and clinical outcomes. Best Pract Res Clin Anaesthesiol. 2021;35(3):449-459. doi:10.1016/j.bpa.2021.02.004

Farshidfar F, Koleini N, Ardehali H. Cardiovascular complications of COVID-19. JCI Insight. 2021;6(13):e148980. doi:10.1172/jci.insight.148980

Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-147. doi:10.1016/j.thromres.2020.04.013

Ooi MWX, Rajai A, Patel R, Gerova N, Godhamgaonkar V, Liong SY. Pulmonary thromboembolic disease in COVID-19 patients on CT pulmonary angiography - prevalence, pattern of disease and relationship to D-dimer. Eur J Radiol. 2020;132:109336. doi:10.1016/j.ejrad.2020.109336

Pérez Dueñas V, Allona Krauel M, Agrela Rojas E, et al. Blue lungs in Covid-19 patients: a step beyond the diagnosis of pulmonary thromboembolism using MDCT with iodine mapping. Arch Bronconeumol. 2021;57:35-46. doi:10.1016/j.arbres.2020.07.031

Vlachou M, Drebes A, Candilio L, et al. Pulmonary thrombosis in Covid-19: before, during and after hospital admission. J Thromb Thrombolysis. 2021;51(4):978-984. doi:10.1007/s11239-020-02370-7

Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA. Thrombosis in COVID-19. Am J Hematol. 2020;95(12):1578-1589. doi:10.1002/ajh.25982

Vidali S, Morosetti D, Cossu E, et al. D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review. ERJ Open Res. 2020;6(2):00260-2020. doi:10.1183/23120541.00260-2020

Semenzato L, Botton J, Drouin J, et al. Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people. Lancet Reg Health Eur. 2021;8:100158. doi:10.1016/j.lanepe.2021.100158

Bairwa M, Kumar R, Beniwal K, Kalita D, Bahurupi Y. Hematological profile and biochemical markers of COVID-19 non-survivors: a retrospective analysis. Clin Epidemiol Glob Health. 2021;11:100770. doi:10.1016/j.cegh.2021.100770

Beidollahkhani S, Fayedeh F, Shoja A, et al. D-dimer as a biomarker for COVID-19-associated pulmonary thromboembolism: a narrative review from molecular pathways to the imaging findings. Egypt J Bronchol. 2023;17(1):44. doi:10.1186/s43168-023-00221-6

Paliogiannis P, Mangoni AA, Dettori P, Nasrallah GK, Pintus G, Zinellu A. D-dimer concentrations and COVID-19 severity: a systematic review and meta-analysis. Front Public Health. 2020;8:432. doi:10.3389/fpubh.2020.00432

Khandait M, Sharma I, Pandit R. D-dimer levels and disease prognosis in COVID-19 patients. J Pure Appl Microbiol. 2021;15(2):819-825. doi:10.22207/JPAM.15.2.36

Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood. 2009;113(13):2878-2887. doi:10.1182/blood-2008-06-165845

Department of Preventive Medicine, Ministry of Health, Vietnam. Situation of infectious diseases and solutions to prevent and control epidemics. 22 February 2023. Accessed 4 November 2024. https://vncdc.gov.vn/tinh-hinh-dich-benh-truyen-nhiem-va-cac-giai-phap-phong-chong-dich-nd17323.html

Hoang V. The COVID-19 pandemic in Vietnam - success, crisis, and endemic: key thresholds and lessons. J Glob Health. 2022;12:03065. doi:10.7189/jogh.12.03065

Statista. State of Health: regional breakdown of cumulative confirmed coronavirus COVID-19 cases in Vietnam as of November 15, 2023. Accessed 4 November 2024. https://www.statista.com/statistics/1103568/vietnam-coronavirus-cases-by-region

World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. doi:10.1001/jama.2013.281053

Minister of Health, Vietnam. Decision No. 2008/QD-BYT: Guidance on Diagnosis and Treatment of COVID-19 Caused by New Corona Virus (SARS-CoV-2). 26 April 2021. Accessed 4 November 2024. https://thuvienphapluat.vn/van-ban/The-thao-Y-te/Quyet-dinh-2008-QD-BYT-2021-huong-dan-dieu-tri-COVID19-do-chung-vi-rut-Corona-moi-472206.aspx

Acar HC, Can G, Karaali R, et al. An easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital. BMC Infect Dis. 2021;21(1):148. doi:10.1186/s12879-021-05845-x

Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18(6):1324-1329. doi:10.1111/jth.14859

Geng J, Yu X, Bao H, et al. Chronic diseases as a predictor for severity and mortality of COVID-19: a systematic review with cumulative meta-analysis. Front Med (Lausanne). 2021;8:588013. doi:10.3389/fmed.2021.588013

Rostami M, Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol. 2020;13(11):1265-1275. doi:10.1080/17474086.2020.1831383

Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. doi:10.1016/S0140-6736(20)30566-3

Marta-Enguita J, Corroza-Laviñeta J, Ostolaza A. Risk factors and severity predictors in COVID-19 hospitalized patients: analysis of 52 patients. Med Clin (Engl Ed). 2020;155(8):360-361. doi:10.1016/j.medcle.2020.06.018

Saurabh A, Dey B, Raphael V, Deb P, Khonglah Y, Tiewsoh I. Role of coagulation profile in predicting disease severity among patients of COVID-19. Cureus. 2021;13(10):e19124. doi:10.7759/cureus.19124

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5

Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood. 2018;131(8):845-854. doi:10.1182/blood-2017-10-804096

Asakura H. Classifying types of disseminated intravascular coagulation: clinical and animal models. J Intensive Care. 2014;2(1):20. doi:10.1186/2052-0492-2-20

Hunt BJ, Levi M. Re The source of elevated plasma D-dimer levels in COVID-19 infection. Br J Haematol. 2020;190(3):e133-e134. doi:10.1111/bjh.16907

Lamichhane A, Pokhrel S, Thapa TB, et al. Associated biochemical and hematological markers in COVID-19 severity prediction. Adv Med. 2023;2023:6216528. doi:10.1155/2023/6216528

Wang D, Li R, Wang J, et al. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study. BMC Infect Dis. 2020;20(1):519. doi:10.1186/s12879-020-05242-w

He X, Yao F, Chen J, et al. The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients. Sci Rep. 2021;11(1):1830. doi:10.1038/s41598-021-81300-w

Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020;92(7):797-806. doi:10.1002/jmv.25783

Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069. doi:10.1001/jama.2020.1585

Woller SC, Stevens SM, Adams DM, et al. Assessment of the safety and efficiency of using an age-adjusted D-dimer threshold to exclude suspected pulmonary embolism. Chest. 2014;146(6):1444-1451. doi:10.1378/chest.13-2386

Miri C, Charii H, Bouazzaoui MA, et al. D-dimer level and diabetes in the COVID-19 infection. Clin Appl Thromb Hemost. 2021;27:10760296211045902. doi:10.1177/10760296211045902

Nasif WA, El-Moursy Ali AS, Hasan Mukhtar M, et al. Elucidating the correlation of D-dimer levels with COVID-19 severity: a scoping review. Anemia. 2022;2022:9104209. doi:10.1155/2022/9104209

Mishra Y, Pathak BK, Mohakuda SS, et al. Relation of D-dimer levels of COVID-19 patients with diabetes mellitus. Diabetes Metab Syndr. 2020;14(6):1927-1930. doi:10.1016/j.dsx.2020.09.035

Yao Y, Cao J, Wang Q, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care. 2020;8:49. doi:10.1186/s40560-020-00466-z

Floyd JS, Walker RL, Kuntz JL, et al. Association between diabetes severity and risks of COVID-19 infection and outcomes. J Gen Intern Med. 2023;38(6):1484-1492. doi:10.1007/s11606-023-08076-9

Gavkare AM, Nanaware N, Rayate AS, Mumbre S, Nagoba BS. COVID-19 associated diabetes mellitus: a review. World J Diabetes. 2022;13(9):729-737. doi:10.4239/wjd.v13.i9.729

Corrao S, Pinelli K, Vacca M, Raspanti M, Argano C. Type 2 diabetes mellitus and COVID-19: a narrative review. Front Endocrinol (Lausanne). 2021;12:609470. doi:10.3389/fendo.2021.609470